Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINESSE: Abciximab and Reteplase in Acute MI
NCT00046228Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2002
- Primary completion
- Jan 2008
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 19
01
Overview
A Phase 3 trial of reteplase, abciximab in ST elevation myocardial infarction (STEMI), sponsored by Janssen Pharmaceutical. Started Aug 2002; status: completed.
02
Drugs
reteplaseabciximab
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00046228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046228.